Chinese Expert Consensus on Antiangiogenic Drugs for Advanced Non-small Cell 
Lung Cancer (2019 Edition)

Benzer Materyaller

• Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
  Yazar:: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-11-01)
• Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)
  Yazar:: Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer
  Baskı/Yayın Bilgisi: (2020-09-01)
• Chinese Expert Consensus on Second-line Treatment for Non-small Cell Lung Cancer with Negative Driver Gene Mutations
  Yazar:: Expert Committee on Non-small Cell Lung Cancer of the Chinese Society of Clinical Oncology
  Baskı/Yayın Bilgisi: (2024-02-01)
• Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer
  Yazar:: Non-small Cell Lung Cancer Expert Committee of Chinese Society of Clinical Oncology, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-03-01)
• Chinese Expert Consensus on the Standardized Diagnosis and Treatment of 
Non‑small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2024 Edition)
  Yazar:: Chinese Society of Clinical Oncology Non-small Cell Lung Cancer Committee
  Baskı/Yayın Bilgisi: (2024-07-01)